Guidelines for laboratory monitoring of treatment of peristent virus infections

Deenan Pillay, VC Emery, David Mutimer, MM Ogilvie, W Carman, K Mutton, T Wreghitt, D Westmoreland, J Breuer, M Zuckerman

Research output: Contribution to journalArticle

10 Citations (Scopus)


A growing number of antiviral agents are available for treatment of persistent viral infections. This has increased the requirment for virology laboratories to undertake sophisticated assays for monitoring the efficacy of treatment and identifying drug failure at an early stage. The consensus guidelines within this article address the laboratory requirements for monitoring treatment of the herpes viruses, HIV-1, Hepatitis B and Hepatitis C. (C) 2002 Elsevier Science B.V. All rights reserved.
Original languageEnglish
Pages (from-to)73-92
Number of pages20
JournalJournal of Clinical Virology
Publication statusPublished - 1 Jan 2002


  • HSV
  • monitoring
  • antiviral compounds
  • CMV
  • MBV
  • VZV
  • HIV-1
  • HCV


Dive into the research topics of 'Guidelines for laboratory monitoring of treatment of peristent virus infections'. Together they form a unique fingerprint.

Cite this